These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1227 related articles for article (PubMed ID: 29866133)
41. Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma. Herzog J; Ehrlich SM; Pfitzer L; Liebl J; Fröhlich T; Arnold GJ; Mikulits W; Haider C; Vollmar AM; Zahler S Oncotarget; 2016 May; 7(19):27108-21. PubMed ID: 27027353 [TBL] [Abstract][Full Text] [Related]
42. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway. Li W; Fu Q; Man W; Guo H; Yang P Eur J Pharmacol; 2019 Apr; 849():106-114. PubMed ID: 30710550 [TBL] [Abstract][Full Text] [Related]
43. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway. Tian L; Huang Y; Liu Y; Liu J; Liu Y IUBMB Life; 2024 Nov; 76(11):972-986. PubMed ID: 38873890 [TBL] [Abstract][Full Text] [Related]
44. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790 [TBL] [Abstract][Full Text] [Related]
45. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo. Wu L; Zhou J; Zhou W; Huang XF; Chen Q; Wang W; Zhai L; Li S; Tang Z Pathol Res Pract; 2021 Apr; 220():153270. PubMed ID: 33640712 [TBL] [Abstract][Full Text] [Related]
46. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo. Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580 [TBL] [Abstract][Full Text] [Related]
47. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression. Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595 [TBL] [Abstract][Full Text] [Related]
48. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma. Xie YX; Liao R; Pan L; Du CY Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554 [TBL] [Abstract][Full Text] [Related]
49. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011 [TBL] [Abstract][Full Text] [Related]
50. Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients. Lv Z; Weng X; Du C; Zhang C; Xiao H; Cai X; Ye S; Cheng J; Ding C; Xie H; Zhou L; Wu J; Zheng S Mol Carcinog; 2016 May; 55(5):1024-33. PubMed ID: 26086159 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA‑302a inhibits cell proliferation and invasion, and induces cell apoptosis in hepatocellular carcinoma by directly targeting VEGFA. Qin C; Zha W; Fan R; Ding H; Xu Y; Wang C Mol Med Rep; 2017 Nov; 16(5):6360-6367. PubMed ID: 28849033 [TBL] [Abstract][Full Text] [Related]
52. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion. Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545 [TBL] [Abstract][Full Text] [Related]
53. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3. Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874 [TBL] [Abstract][Full Text] [Related]
54. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
56. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways. Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy. Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641 [TBL] [Abstract][Full Text] [Related]
58. HANR promotes lymphangiogenesis of hepatocellular carcinoma via secreting miR-296 exosome and regulating EAG1/VEGFA signaling in HDLEC cells. Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L J Cell Biochem; 2019 Oct; 120(10):17699-17708. PubMed ID: 31127654 [TBL] [Abstract][Full Text] [Related]
59. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma. Zhang HF; Li W; Han YD Cancer Biomark; 2018 Feb; 21(3):575-582. PubMed ID: 29278875 [TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]